78 related articles for article (PubMed ID: 6538405)
1. [Effect of CDDP administration on NK activity of human peripheral lymphocytes and its modification by corticosteroid as anti-emetic agent].
Takahashi K; Saijo N; Seki S; Kimata M; Sasaki Y; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Hoshi A
Gan To Kagaku Ryoho; 1984 Mar; 11(3):492-6. PubMed ID: 6538405
[TBL] [Abstract][Full Text] [Related]
2. [Corticosteroid as an anti-emetic agent in cancer chemotherapy with cis-diammine-dichloroplatinum (II)].
Samma S; Yoshikawa M; Futami T; Hayashi Y; Horii Y; Kubota K; Babaya K; Hirao Y; Okajima E; Ohara S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):561-5. PubMed ID: 4039918
[TBL] [Abstract][Full Text] [Related]
3. Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.
Takahashi K; Saijo N; Kimata M; Sasaki Y; Fujita J; Futami H; Shimizu E; Eguchi K; Shinkai T; Tominaga K
J Cancer Res Clin Oncol; 1985; 109(1):78-81. PubMed ID: 3919031
[TBL] [Abstract][Full Text] [Related]
4. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cisplatinum (CDDP) and combined chemotherapy with CDDP on peripheral blood lymphocyte natural killer (NK) activity].
Baba M; Shibuya M; Iizuka K; Sakai S; Hirata S; Ohtsuka M; Aoyama A; Niitani H; Koizumi K; Shohji T
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3299-302. PubMed ID: 2551255
[No Abstract] [Full Text] [Related]
7. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
[TBL] [Abstract][Full Text] [Related]
8. [Effects of separate administration of low-dose CDDP on antitumor immune reactivity for treatment of malignant glioma].
Nishihara T; Tanaka S; Murakami M; Hirakawa M; Nagashima T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1197-202. PubMed ID: 7661572
[TBL] [Abstract][Full Text] [Related]
9. [Cis-dichlorodiammine platinum (II) CDDP in the treatment of non-small cell lung cancer].
Eguchi K; Shimizu E; Saijo N; Sasaki Y; Shinkai T; Tominaga K
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1764-9. PubMed ID: 6541021
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group].
Uchida K; Akaza H; Shimazui T; Kikuchi K; Manabe F; Iwasaki A; Ishikawa S; Noguchi R; Otani M; Hattori K; Kondo F; Nishijima Y; Sato K; Koiso K; Hinotsu S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):81-6. PubMed ID: 8546475
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
Tsavaris N; Kosmas CH; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos CH
J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of suppressor cells activity by cis-diamminedichloroplatinum (CDDP) treatment using therapeutic doses in ovarian cancer patients.
Tsuda H; Kitahashi S; Umesaki N; Kanaoka Y; Kawabata M; Ogita S
Gynecol Oncol; 1994 Feb; 52(2):218-21. PubMed ID: 8314142
[TBL] [Abstract][Full Text] [Related]
13. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
15. [Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Tanaka K; Sekine M; Serikawa T; Sanada H; Shichiri K; Fujimori R
Gan To Kagaku Ryoho; 1998 May; 25(6):907-13. PubMed ID: 9617330
[TBL] [Abstract][Full Text] [Related]
16. [Influence of a fosfomycin combination on the anti-tumor effect of CDDP].
Sagara N; Nakano K; Aizawa M; Hara S; Inufusa H; Mori N; Kurooka K; Haeno Y; Yasutomi M
Gan To Kagaku Ryoho; 1988 Jan; 15(1):97-100. PubMed ID: 3337531
[TBL] [Abstract][Full Text] [Related]
17. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
19. [Effect of granisetron in preventing emesis due to anti-cancer drug (CDDP) administration pulmo-mediastinal malignancies--comparison of simultaneous infusion with the conventional method of administration].
Nakahara K; Minami M; Yasumitsu T; Ikeda M; Ohta M; Nakamura K; Akashi A; Kido T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):571-6. PubMed ID: 9530364
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
